GENOTOXIC AND CARCINOGENIC STUDIES OF NORGESTREL IN DROSOPHILA MELANOGASTER

Authors

  • AHMED ABOU-EISHA Department of Cell Biology, National Research Centre, 33 El-Bohouth St., Dokki, Giza, P.O. Box 12622, Egypt. http://orcid.org/0000-0001-9256-1056
  • Adel E El-din Department of Cell Biology, National Research Centre, 33 El-Bohouth St., Dokki, Giza, P.O. Box 12622, Egypt. http://orcid.org/0000-0001-5221-6581

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i10.27374

Keywords:

Norgestrel, Wing-spot assay, Comet assay, Warts-based somatic mutation and recombination test

Abstract

Objective: The aim of this study was to investigate, for the first time, the possible in vivo genotoxic and carcinogenic activity associated with exposure to norgestrel (NGT) drug through employing the very recently established and adjusted genotoxic and tumorigenic methods in Drosophila melanogaster.

Methods: Two in vivo genotoxic test systems were used; one detects the somatic mutation and recombination effects (somatic mutation and recombination test [SMART] wing-spot test) and the other detects the primary DNA damage (the comet test) in the body cells of D. melanogaster. On the other hand, the warts (wts)-based SMART assay is a vital genetic examination in Drosophila used to identify and characterize cancer potential of compounds.

Results: Four experimental doses of NGT were used (ranging from 0.24 μM to 16 μM). NGT was found to be non-genotoxic at all tested concentrations even at the highest dose level 16 μM and failed to increase the frequency of tumors in the somatic cells of D. melanogaster.

Conclusion: Our results strengthen the hypothesis that steroidal drugs might act through a non-genotoxic carcinogen mechanism where the carcinogenic properties occur by direct stimulation of cellular proliferation through a steroid receptor-mediated mechanism. In addition, the results obtained in this research work may contribute to highlighting the importance of NGT as a potent neuroprotective antioxidant drug.

Downloads

Download data is not yet available.

References

Siddique YH, Ara G, Beg T, Afzal M. Additive action of vitamin C and E against norgestrel induced genotoxicity. Biomed Res 2007;18:155-60.

Hebbar S. Epilepsy and oral hormonal contraception-Indian perspective. Int J Pharm Pharm Sci 2017;9:1-6.

Doonan F, O’Driscoll C, Kenna P, Cotter TG. Enhancing survival of photoreceptor cells in vivo using the synthetic progestin Norgestrel. J Neurochem 2011;118:915-27.

Byrne AM, Ruiz-Lopez AM, Roche SL, Moloney JN, Wyse- Jackson AC, Cotter TG. The synthetic progestin norgestrel modulates Nrf2 signalling and acts as an antioxidant in a model of retinal degeneration. Redox Biol 2016;10:128-39.

Jackson AC, Cotter TG. The synthetic progesterone norgestrel is neuroprotective in stressed photoreceptor-like cells and retinal explants, mediating its effects via basic fibroblast growth factor, protein kinase A and glycogen synthase kinase 3beta signalling. Eur J Neurosci 2016;43:899-911.

Ahmad ME, Shadab GG, Azfer MA, Afzal M. Evaluation of genotoxic potential of synthetic progestins-norethindrone and norgestrel in human lymphocytes in vitro. Mutat Res 2001;494:13-20.

Siddique YH, Beg T, Afzal M. Anticlastogenic effects of ascorbic acid against the genotoxic damage induced by norethynodrel. Adv Environ Biol 2007;1:27-32.

Goyette S, Liang Y, Mafuvadze B, Cook MT, Munir M, Hyder SM, et al. Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro. Breast Cancer (Dove Med Press) 2017;9:347-57.

Willibald M, Bayer G, Stahlhut V, Poschmann G, Stühler K, Gierke B, et al. progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells. Oncotarget 2017;8:72480-93.

Siddique YH, Afzal M. Evaluation of genotoxic potential of synthetic progestin chlormadinone acetate. Toxicol Lett 2004;153:221-5.

Siddique YH, Ara G, Beg T, Afzal M. Genotoxic potential of medroxyprogesterone acetate in cultured human peripheral blood lymphocytes. Life Sci 2006;80:212-8.

Siddique Y, Afzal M. A review on the genotoxic effects of some synthetic progestins. Int J Pharmacol 2008;4:410-30.

Siddique YH, Beg T, Afzal M. Protective effect of nordihydroguaiaretic acid (NDGA) against norgestrel induced genotoxic damage. Toxicol In Vitro 2006;20:227-33.

Abou-Eisha A, El-Din AE, Darwish HR. Assessment of mutagenic activity of 17Î’-estradiol in Drosophila melanogaster. Fresen Environ Bull 2016;25:1729-36.

Carmona ER, Guecheva TN, Creus A, Marcos R. Proposal of an in vivo comet assay using haemocytes of Drosophila melanogaster. Environ Mol Mutagen 2011;52:165-9.

Vidal M, Cagan RL. Drosophila models for cancer research. Curr Opin Genet Dev 2006;16:10-6.

Bonneton F, Laudet V. Evolution of nuclear receptors in insects. In: Gilbert LI, editor. Insect Endocrinology. 1st ed. San Diego: Academic Press; 2012. p. 219-52.

Sidorov RA, Ugnivenko EG, Khovanova EM, Belitsky GA. Induction of tumor clones in D. melanogaster wts/+ heterozygotes with chemical carcinogens. Mutat Res 2001;498:181-91.

Nazir A, Mukhopadhyay I, Saxena DK, Chowdhuri DK. Evaluation of the no observed adverse effect level of solvent dimethyl sulfoxide in Drosophila melanogaster. Toxicol Mech Methods 2003;13:147-52.

Tsuda H, Takeda N. Effect of tumor promoter TPA on spontaneous and mitomycin C induced mitotic recombination in Drosophila melanogaster. Mutat Res 1987;189:375-9.

Eeken JC, Klink I, van Veen BL, Pastink A, Ferro W. Induction of epithelial tumors in Drosophila melanogaster heterozygous for the tumor suppressor gene wts. Environ Mol Mutagen 2002;40:277-82.

Dhanraj V, Manivasagam T, Karuppaiah J. Myricetin isolated from turbinaria ornata ameliorates rotenone induced parkinsonism in Drosophila melanogaster. Int J Pharm Pharm Sci 2017;9:39-44.

Marcos R, Carmona ER. The wing-spot and the comet tests as useful assays detecting genotoxicity in Drosophila. In: Dhawan A, Bajpayee M, editors. Genotoxicity Assessment: Methods and Protocol. Vol. 1044. New York: Humana Press; 2013. p. 417-27.

Graf U, Würgler F, Katz A, Frei H, Juon H, Hall C, et al. Somatic mutation and recombination test in Drosophila melanogaster. Environ Mol Mutagen 1984;6:153-88.

Demir E, KocaoÄŸlu S, Kaya B. Antigenotoxic properties of chlorophyllin and chlorophylls in the Drosophila wing spot test. Fresen Environ Bull 2010;19:3131-8.

Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-91.

Kumaravel TS, Jha AN. Reliable comet assay measurements for detecting DNA damage induced by ionising radiation and chemicals. Mutat Res 2006;605:7-16.

Lovell DP, Omori T. Statistical issues in the use of the comet assay. Mutagenesis 2008;23:171-82.

Kastenbaum MA, Bowman KO. Tables for determining the statistical significance of mutation frequencies. Mutat Res 1970;9:527-49.

Frei H, Würgler FE. Statistical methods to decide whether mutagenicity test data from Drosophila assays indicate a positive, negative, or inconclusive result. Mutat Res 1988;203:297-308.

Franchi LP, Guimarães NN, De Andrade LR, De Andrade HH, Lehmann M, Dihl RR, et al. Antimutagenic and antirecombinagenic activities of noni fruit juice in somatic cells of Drosophila melanogaster. An Acad Bras Cienc 2013;85:585-94.

Hartmann A, Schumacher M, Plappert-Helbig U, Lowe P, Suter W, Mueller L, et al. Use of the alkaline in vivo comet assay for mechanistic genotoxicity investigations. Mutagenesis 2004;19:51-9.

Dhawan A, Bajpayee M, Parmar D. Comet assay: A reliable tool for the assessment of DNA damage in different models. Cell Biol Toxicol 2009;25:5-32.

Tsutsui T, Barrett JC. Neoplastic transformation of cultured mammalian cells by estrogens and estrogen like chemicals. Environ Health Perspect 1997;105 Suppl 3:619-24.

Jordan A. Toxicology of progestogens of implantable contraceptives for women. Contraception 2002;65:3-8.

Bajpayee M, Pandey AK, Parmar D, Mathur N, Seth PK, Dhawan A. Comet assay responses in human lymphocytes are not influenced by the menstrual cycle: A study in healthy Indian females. Mutat Res 2005;565:163-72.

Braz MG, Fávero Salvadori DM. Influence of endogenous and synthetic female sex hormones on human blood cells in vitro studied with comet assay. Toxicol In Vitro 2007;21:972-6.

Backman T, Rauramo I, Jaakkola K, Inki P, Vaahtera K, Launonen A, et al. Use of the levonorgestrel-releasing intrauterine system and breast cancer. Obst Gynecol 2005;106:813-7.

Kresowik J, Ryan GL, Van Voorhis BJ. Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system. Obstet Gynecol 2008;111:547-9.

Runnalls TJ, Beresford N, Losty E, Scott AP, Sumpter JP. Several synthetic progestins with different potencies adversely affect reproduction of fish. Environ Sci Technol 2013;47:2077-84.

Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev 1997;18:502-19.

Catherino WH, Jeng MH, Jordan VC. Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism. Br J Cancer 1993;67:945-52.

Liang Y, Benakanakere I, Besch-Williford C, Hyder RS, Ellersieck MR, Hyder SM, et al. Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice. Menopause 2010;17:1040-7.

Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J. Role of nrf2/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism. Cell Mol Life Sci 2016;73:3221-47.

Reed DJ. Glutathione: Toxicological implications. Annu Rev Pharmacol Toxicol 1990;30:603-31.

Chandrasena RE, Edirisinghe PD, Bolton JL, Thatcher GR. Problematic detoxification of estrogen quinones by NAD(P)H-dependent quinone oxidoreductase and glutathione-S-transferase. Chem Res Toxicol 2008;21:1324-9.

Raftogianis R, Creveling C, Weinshilboum R, Weisz J. Estrogen metabolism by conjugation. JNCI Monographs 2000;2000:113-24.

Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Chapter 4: Estrogens as endogenous genotoxic agents—DNA adducts and mutations. JNCI Monographs 2000;2000:75-94.

Zahid M, Saeed M, Ali MF, Rogan EG, Cavalieri EL. N-acetylcysteine blocks formation of cancer-initiating estrogen–DNA adducts in cells. Free Rad Biol Med 2010;49:392-400.

Parkes TL, Hilliker AJ, Phillips JP. Genetic and biochemical analysis of glutathione-S-transferase in the oxygen defense system of Drosophila melanogaster. Genome 1993;36:1007-14.50.

Hunaiti AA, Elbetieha AM, Obeidat MA, Owais WM. Developmental studies on Drosophila melanogaster glutathione S-transferase and its induction by oxadiazolone. Insect Biochem Mol Biol 1995;25:1115-9.

Published

07-10-2018

How to Cite

ABOU-EISHA, A. ., and A. E. El-din. “GENOTOXIC AND CARCINOGENIC STUDIES OF NORGESTREL IN DROSOPHILA MELANOGASTER”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 10, Oct. 2018, pp. 372-7, doi:10.22159/ajpcr.2018.v11i10.27374.

Issue

Section

Original Article(s)